USFDA completes cGMP inspection at Chennai formulations facility of Strides Pharma Science’s arm

06 Apr 2024 Evaluate

United States Food and Drug Administration (USFDA) has completed a routine current Good Manufacturing Practices (cGMP) inspection at Strides Pharma Science’s wholly owned subsidiary -- Strides Alathur’s Chennai formulations facility. The inspection was conducted from April 1, 2024 to April 5, 2024. 

The inspection closed with two observations. The company will respond to these observations comprehensively to FDA within the stipulated time. 

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

684.30 -15.00 (-2.15%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.